Bill

Bill > HB0767


TN HB0767

TN HB0767
AN ACT to amend Tennessee Code Annotated, Title 67, Chapter 4, Part 7, relative to taxation.


summary

Introduced
02/04/2025
In Committee
02/06/2025
Crossed Over
Passed
Dead

Introduced Session

114th General Assembly

Bill Summary

As introduced, exempts from business tax, receipts from the sale of a prescription drug or medicine with a cost for a 30-day equivalent supply that exceeds the medicare cost threshold for 2025 plan years and services necessary for proper preparation, storage, handling, administration, patient education, or post-sale monitoring of such exempted drugs or medicines. - Amends TCA Title 67, Chapter 4, Part 7.

AI Summary

This bill amends Tennessee tax law to create a new exemption for certain high-cost prescription drugs and related services from business taxation. Specifically, the legislation will exempt from business tax any prescription drugs or medicines that have a 30-day supply cost exceeding the Medicare Part D specialty tier cost threshold for 2025, as determined by the federal Centers for Medicare and Medicaid Services (CMS). Additionally, the bill provides a tax exemption for services directly related to these drugs, including preparation, storage, handling, administration, patient education, and post-sale monitoring. By targeting drugs that are particularly expensive, the bill aims to reduce the financial burden on patients and healthcare providers for high-cost medications. The tax exemption will take effect on July 1, 2025, giving businesses and healthcare systems time to prepare for the change. This legislation modifies existing Tennessee tax code sections 67-4-708 and 67-4-712 to implement these new exemptions.

Committee Categories

Budget and Finance

Sponsors (1)

Last Action

Action Def. in s/c Finance, Ways, and Means Subcommittee to the Final Calendar 2 (on 04/01/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...